Dihydroartemisinin acts by generating reactive oxygen species within the parasite, leading to oxidative stress and damage to essential proteins and membranes. This rapid action is particularly effective against the asexual blood stages of the Plasmodium species, the causative agents of malaria. DHA is often combined with partner drugs in [artemisinin-based combination therapies (ACTs)]() to improve outcomes and prevent the development of resistance.